COVID-19: VACCINE WATCH

Pfizer says its vaccine is 90.7% effective against symptomatic Covid-19 in children ages 5 to 11

Oct 22, 2021, 9:50 AM
Bridgette Melo, 5, holds the hand of her father, Jim Melo, during her inoculation of one of two red...
Bridgette Melo, 5, holds the hand of her father, Jim Melo, during her inoculation of one of two reduced 10 ug doses of the Pfizer BioNtech COVID-19 vaccine during a trial at Duke University in Durham, North Carolina September 28, 2021 in a still image from video. Video taken September 28, 2021. Shawn Rocco/Duke University/Handout via REUTERS NO RESALES. NO ARCHIVES. THIS IMAGE HAS BEEN SUPPLIED BY A THIRD PARTY.
Originally Published: 22 OCT 21 08:52 ET
Updated: 22 OCT 21 10:21 ET

    (CNN) — In a new document posted ahead of a key meeting of the US Food and Drug Administration’s vaccine advisers, Pfizer says its vaccine is safe and 90.7% effective against symptomatic Covid-19 in children ages 5 to 11.

In the trial, which included around 2,000 children, there were three Covid-19 cases among the group that received the vaccine and 16 cases in the placebo group. In the trial, twice as many children received the vaccine as the placebo.

Pfizer/BioNTech are seeking FDA emergency use authorization of a two-dose regimen of their 10-microgram dose for children ages 5 to 11. The two doses would be administered three weeks apart.

Last month, Pfizer released details of a Phase 2/3 trial that showed its Covid-19 vaccine was safe and generated a “robust” antibody response in children ages 5 to 11. The trial included 2,268 participants ages 5 to 11. Participants’ immune responses were measured by looking at neutralizing antibody levels in their blood and comparing those levels to a control group of 16- to 25-year-olds who were given a two-dose regimen with the larger 30-microgram dose. Pfizer said the levels compared well with older people who received the larger dose, demonstrating a “strong immune response in this cohort of children one month after the second dose.”

The FDA’s Vaccines and Related Biological Products Advisory Committee is scheduled to meet October 26 to discuss whether to recommend the vaccine for authorization for those ages 5 to 11.

If authorized, this would be the first Covid-19 vaccine for younger children. The Pfizer/BioNTech vaccine is approved for people age 16 and older and has an EUA for people ages 12 to 15.

The-CNN-Wire
™ & © 2021 Cable News Network, Inc., a WarnerMedia Company. All rights reserved.

Today’s Top Stories

COVID-19: Vaccine Watch

covid pill...
Curt Gresseth

Utah doctor weighs in on new COVID-19 pill you can take at home

A University of Utah doctor specializing in infectious diseases weighs the pros and cons on a new pill taken at home to treat coronavirus.
21 hours ago
FILE: A woman and her husband sign up on their phone to get COVID-19 swab tests at the Utah County ...
Simone Seikaly

Here’s where you can get a COVID-19 test in Utah this week

Tests are provided by Test Utah, Tour Health, and the Utah Department of Health. This is not an exhaustive list of COVID-19 test sites in Utah.
21 hours ago
chief scientist Utah lab Salt Lake company corona virus...
Kelsey Earl

Chief scientist at Utah Lab helps identify Omicron in Utah

The Chief Scientist at a Utah lab helped spot the Omicron variant in Utah.
3 days ago
Omicron variant Photo: Canva...
Becky Bruce

Omicron variant of COVID-19 detected in first Utah patient

Utah health officials confirmed the state's first patient to test positive for the omicron variant of COVID-19 Friday. 
4 days ago
Omicron variant Photo: Canva...
Eliza Craig

Omicron variant confirmed in Minnesota

Health Officials in Minnesota have just confirmed a positive case of the omicron variant a day after confirmed case in California.
5 days ago
COVID-19 Virus. Photo: Canva...
Eliza Craig

COVID-19 update: 2,300 new cases

The Utah Department of Health reported 2,297 new cases of COVID-19 on Wednesday, for a total of 598,098 since the pandemic began. 
6 days ago
Pfizer says its vaccine is 90.7% effective against symptomatic Covid-19 in children ages 5 to 11